Skip to main content
. 2020 Apr 29;10:7251. doi: 10.1038/s41598-020-64352-2

Figure 1.

Figure 1

Multi-step resistance selection for auranofin, clindamycin, and mupirocin evaluated against S. aureus. Drugs were serially passaged daily against (A) S. aureus ATCC 6538 and (B) methicillin-resistant S. aureus (MRSA) NRS384 (USA300) for 14 days. The minimum inhibitory concentration (MIC) of each test agent was determined after each passage. Data are presented as fold-change in MIC relative to the previous passage.